Cargando…
Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
PURPOSE OF REVIEW: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with a chronic and often progressive disease course. The current disease-modifying treatments (DMTs) limit disease progression primarily by dampening immune cell activity in the peripheral blood...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607648/ https://www.ncbi.nlm.nih.gov/pubmed/36301434 http://dx.doi.org/10.1007/s11910-022-01229-z |